Cargando…

Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection

OBJECTIVE: Analyzing the risk factors for pneumonia development in breakthrough cases with a history of inactivated vaccine injection is important. The present study aimed to investigate the risk factors for pneumonia development during Omicron variant infection. DESIGN AND METHODS: The clinical dat...

Descripción completa

Detalles Bibliográficos
Autores principales: Tong, Xuecheng, Huang, Zeyu, Zhang, Xiujun, Si, Guocan, Lu, Huifen, Zhang, Wei, Xue, Yuan, Xie, Weibin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512030/
https://www.ncbi.nlm.nih.gov/pubmed/36172623
http://dx.doi.org/10.2147/IDR.S380005
_version_ 1784797767491649536
author Tong, Xuecheng
Huang, Zeyu
Zhang, Xiujun
Si, Guocan
Lu, Huifen
Zhang, Wei
Xue, Yuan
Xie, Weibin
author_facet Tong, Xuecheng
Huang, Zeyu
Zhang, Xiujun
Si, Guocan
Lu, Huifen
Zhang, Wei
Xue, Yuan
Xie, Weibin
author_sort Tong, Xuecheng
collection PubMed
description OBJECTIVE: Analyzing the risk factors for pneumonia development in breakthrough cases with a history of inactivated vaccine injection is important. The present study aimed to investigate the risk factors for pneumonia development during Omicron variant infection. DESIGN AND METHODS: The clinical data were retrospectively collected from 187 patients who previously received inactivated vaccine and were infected by the Omicron variant. RESULTS: Among the 187 patients, 73 had 2 doses of inactivated vaccine injection and the remaining 114 had 3 doses; 19 patients had pneumonia at admission. The univariate logistic analysis showed that age, baseline platelet count, D-dimer level, and CD8(+) T lymphocyte count were associated with pneumonia development at admission. The multivariate analysis showed that only age was the independent risk factor for pneumonia development (odds ratio = 1.046, 95% confidence interval: 1.003–1.091, P = 0.04). With an optimal cutoff value of 46, 4.4% (4/91) patients in the age <46 years group and 15.63% (15/96) patients in the age ≥46 years group had pneumonia (χ(2) = 6.454, P = 0.01). Moreover, age negatively correlated with CD8(+) T cell count, B cell count, and albumin and uric acid levels (all P < 0.01), while age positively correlated with the glucose level (P < 0.01). CONCLUSION: Old age was the only independent risk factor for pneumonia development in patients with Omicron variant infection and a history of inactivated vaccine injection.
format Online
Article
Text
id pubmed-9512030
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Dove
record_format MEDLINE/PubMed
spelling pubmed-95120302022-09-27 Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection Tong, Xuecheng Huang, Zeyu Zhang, Xiujun Si, Guocan Lu, Huifen Zhang, Wei Xue, Yuan Xie, Weibin Infect Drug Resist Original Research OBJECTIVE: Analyzing the risk factors for pneumonia development in breakthrough cases with a history of inactivated vaccine injection is important. The present study aimed to investigate the risk factors for pneumonia development during Omicron variant infection. DESIGN AND METHODS: The clinical data were retrospectively collected from 187 patients who previously received inactivated vaccine and were infected by the Omicron variant. RESULTS: Among the 187 patients, 73 had 2 doses of inactivated vaccine injection and the remaining 114 had 3 doses; 19 patients had pneumonia at admission. The univariate logistic analysis showed that age, baseline platelet count, D-dimer level, and CD8(+) T lymphocyte count were associated with pneumonia development at admission. The multivariate analysis showed that only age was the independent risk factor for pneumonia development (odds ratio = 1.046, 95% confidence interval: 1.003–1.091, P = 0.04). With an optimal cutoff value of 46, 4.4% (4/91) patients in the age <46 years group and 15.63% (15/96) patients in the age ≥46 years group had pneumonia (χ(2) = 6.454, P = 0.01). Moreover, age negatively correlated with CD8(+) T cell count, B cell count, and albumin and uric acid levels (all P < 0.01), while age positively correlated with the glucose level (P < 0.01). CONCLUSION: Old age was the only independent risk factor for pneumonia development in patients with Omicron variant infection and a history of inactivated vaccine injection. Dove 2022-09-21 /pmc/articles/PMC9512030/ /pubmed/36172623 http://dx.doi.org/10.2147/IDR.S380005 Text en © 2022 Tong et al. https://creativecommons.org/licenses/by-nc/3.0/This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/ (https://creativecommons.org/licenses/by-nc/3.0/) ). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php).
spellingShingle Original Research
Tong, Xuecheng
Huang, Zeyu
Zhang, Xiujun
Si, Guocan
Lu, Huifen
Zhang, Wei
Xue, Yuan
Xie, Weibin
Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title_full Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title_fullStr Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title_full_unstemmed Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title_short Old Age is an Independent Risk Factor for Pneumonia Development in Patients with SARS-CoV-2 Omicron Variant Infection and a History of Inactivated Vaccine Injection
title_sort old age is an independent risk factor for pneumonia development in patients with sars-cov-2 omicron variant infection and a history of inactivated vaccine injection
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9512030/
https://www.ncbi.nlm.nih.gov/pubmed/36172623
http://dx.doi.org/10.2147/IDR.S380005
work_keys_str_mv AT tongxuecheng oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT huangzeyu oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT zhangxiujun oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT siguocan oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT luhuifen oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT zhangwei oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT xueyuan oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection
AT xieweibin oldageisanindependentriskfactorforpneumoniadevelopmentinpatientswithsarscov2omicronvariantinfectionandahistoryofinactivatedvaccineinjection